Laboratory testing service

Notice of Intent to Sole Source for Genome Wide Methylation Service

The National Institutes of Health intends to award a Firm-Fixed-Price purchase order to Diagenode, Inc. located at 400 Morrison Avenue, Suite 101, Denville, NJ  07834.

In accordance with FAR Part 6.302-1, the Contractor is the only known responsible source who can provide the required services as no other source has been identified who can provide the requirement listed below within the required timeframe of two to three weeks.

The NIH requires genome-wide methylation.  This methylation experiment is essential to the completion of AMD and Aging projects currently underway as the samples have already been subjected to RNA-Sequencing and the data has already been analyzed.  For full interpretation of the RNA-Seq experiments, the NIH needs the methylation data to provide the epigenetics information needed.  Diagenode, Inc. can provide a turnaround time of two-three weeks upon receipt of samples for the diagnostic assays. 

This notice is not a request for competitive quotes.  However, any party that believes it can meet the requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government.

It is anticipated that an award will be issued approximately seven (7) days after the date of this notice unless the Government determines that another organization has the capability to meet this requirement.

Please email responses to zetherine.gore@nih.hhs.gov no later than 12:00 p.m. EST on Friday, May 7,   2021.